Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.

[1]  Claudia Salomone,et al.  Sarcoma histiocítico cutáneo. Reporte de un caso , 2009 .

[2]  M. Abidi,et al.  Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant , 2007, American journal of hematology.

[3]  M. Miettinen,et al.  Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163 , 2005, Modern Pathology.

[4]  S. Teo.  Properties of thalidomide and its analogues: Implications for anticancer therapy , 2005, The AAPS Journal.

[5]  J. Strong,et al.  Histiocytic sarcoma with fatal duodenal ulcers. , 2004, Pathology, research and practice.

[6]  I. Yakoub-Agha,et al.  Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow tranplantation for T-ALL , 2003, Leukemia.

[7]  R. Warnke,et al.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases , 2002, Histopathology.

[8]  A. Lee,et al.  Primary Histiocytic Lymphoma of the Central Nervous System: A Neoplasm Frequently Overshadowed by a Prominent Inflammatory Component , 2001, The American journal of surgical pathology.

[9]  P. Fenaux,et al.  Successful autologous bone marrow transplantation in second remission of malignant histiocytosis. , 1990, Bone marrow transplantation.

[10]  G. Mathé,et al.  The Two Varieties of Lymphoid Tissue “Reticulosarcomas” Histiocytic and Histioblastic Types , 1970, British Journal of Cancer.